[1] |
CIPRIANO A, MACHADO A, SANTOS F V, et al. Human psittacosis: a case report[J]. Acta Med Port,2019,32(2):161-164. doi: 10.20344/amp.10079 |
[2] |
LENZ H, NORBY G O, DAHL V, et al. Five-year mortality in patients treated for severe community-acquired pneumonia-a retrospective study[J]. Acta Anaesthesiol Scand,2017,61(4):418-426. doi: 10.1111/aas.12863 |
[3] |
瞿介明, 曹 彬. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(4):253-279. doi: 10.3760/cma.j.issn.1001-0939.2016.04.005 |
[4] |
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学, 2016, 36(2):97-107. doi: 10.3969/j.issn.1002-1949.2016.02.001 |
[5] |
替考拉宁临床应用剂量专家共识组. 替考拉宁临床应用剂量专家共识[J]. 中华结核和呼吸杂志, 2016, 39(7):500-508. doi: 10.3760/cma.j.issn.1001-0939.2016.07.002 |
[6] |
CHEN H, LI L, WU M M, et al. Efficacy and safety of linezolid versus teicoplanin for the treatment of MRSA infections: a meta-analysis[J]. J Infect Dev Countr,2018,11(12):926-934. doi: 10.3855/jidc.9447 |
[7] |
JIANG H, TANG R N, WANG J. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials[J]. Eur J Clin Microbiol Infect Dis,2013,32(9):1121-1128. doi: 10.1007/s10096-013-1867-z |
[8] |
FU J J, YE X H, CHEN C, et al. The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections[J]. PLoS One,2013,8(3):e58240. doi: 10.1371/journal.pone.0058240 |
[9] |
LI Y, XU W. Efficacy and safety of linezolid compared with other treatments for skin and soft tissue infections: a meta-analysis[J]. Biosci Rep,2018,38(1):BSR20171125. doi: 10.1042/BSR20171125 |
[10] |
中国医药教育协会感染疾病专业委员会. 抗菌药物药代动力学/药效学理论临床应用专家共识[J]. 中华结核和呼吸杂志, 2018, 41(6):409-446. doi: 10.3760/cma.j.issn.1001-0939.2018.06.004 |
[11] |
VANDE WEYGAERDE Y, VERSTEELE C, THIJS E, et al. An unusual presentation of a case of human psittacosis[J]. Respir Med Case Rep,2018,23:138-142. |
[12] |
REISINGER A C, SCHILCHER G, PRATTES J, et al. Acute respiratory distress syndrome during a pandemic-an obvious diagnosis? Lancet Infect Dis,2020,20(7):873. doi: 10.1016/S1473-3099(20)30468-0 |
[13] |
许官升. 多西环素联合阿奇霉素治疗支原体肺炎疗效研究[J]. 中国实用医药, 2018, 13(15):128-129. |
[14] |
张凤芝. 阿奇霉素联合多西环素治疗成人支原体肺炎效果观察[J]. 临床合理用药杂志, 2018, 11(25):66-67. |
[15] |
LU Z M, HOU M L, LI D D, et al. Azithromycin combined with doxycycline in non-gonococcal urethritis[J]. Exp Ther Med,2020,20(4):3887-3894. |
[16] |
中国成人念珠菌病诊断与治疗专家共识组. 中国成人念珠菌病诊断与治疗专家共识[J]. 中华内科杂志, 2020, 59(1):5-17. doi: 10.3760/cma.j.issn.0578-1426.2020.01.002 |
[17] |
SPOORENBERG S M, BOS W J, VAN HANNEN E J, et al. Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch hospitals[J]. Neth J Med,2016,74(2):75-81. |
[18] |
SHEN T, LIU Y X, SHANG J, et al. Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology,2019,156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002 |
[19] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Drug-induced liver injury[J]. J Hepatol,2019,70(6):1222-1261. doi: 10.1016/j.jhep.2019.02.014 |
[20] |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 肝脏, 2015, 20(10):750-767. doi: 10.3969/j.issn.1008-1704.2015.10.002 |
[21] |
陈 煜. 阿奇霉素和克拉霉素治疗患者药物不良反应的临床分析[J]. 北方药学, 2020, 17(7):186-187. doi: 10.3969/j.issn.1672-8351.2020.07.138 |
[22] |
SZKOLNICKA D, LUCENDO-VILLARIN B, MOORE J K, et al. Reducing hepatocyte injury and necrosis in response to paracetamol using noncoding RNAs[J]. Stem Cells Transl Med,2016,5(6):764-772. doi: 10.5966/sctm.2015-0117 |
[23] |
尹小萍, 王 辰. 临床药师对抗菌药物致急性药物性肝损伤的药学监护[J]. 中国医院用药评价与分析, 2017, 17(10):1434-1436. |